Your browser doesn't support javascript.
loading
Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives.
Eratne, Dhamidhu; Janelidze, Shorena; Malpas, Charles B; Loi, Samantha; Walterfang, Mark; Merritt, Antonia; Diouf, Ibrahima; Blennow, Kaj; Zetterberg, Henrik; Cilia, Brandon; Wannan, Cassandra; Bousman, Chad; Everall, Ian; Zalesky, Andrew; Jayaram, Mahesh; Thomas, Naveen; Berkovic, Samuel F; Hansson, Oskar; Velakoulis, Dennis; Pantelis, Christos; Santillo, Alexander.
Afiliação
  • Eratne D; Neuropsychiatry, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Janelidze S; Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Melbourne, VIC, Australia.
  • Malpas CB; Clinical Memory Research Unit, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
  • Loi S; Clinical Outcomes Research Unit (CORe), Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
  • Walterfang M; Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Merritt A; Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, VIC, Australia.
  • Diouf I; Neuropsychiatry, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Blennow K; Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Melbourne, VIC, Australia.
  • Zetterberg H; Neuropsychiatry, The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Cilia B; Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Melbourne, VIC, Australia.
  • Wannan C; Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Melbourne, VIC, Australia.
  • Bousman C; Clinical Outcomes Research Unit (CORe), Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
  • Everall I; Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Zalesky A; Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, University of Gothenburg, Mölndal, Sweden.
  • Jayaram M; Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, University of Gothenburg, Mölndal, Sweden.
  • Thomas N; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Berkovic SF; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.
  • Hansson O; UK Dementia Research Institute, University College London (UCL), London, UK.
  • Velakoulis D; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.
  • Pantelis C; The University of Melbourne, Parkville, VIC, Australia.
  • Santillo A; Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Melbourne, VIC, Australia.
Aust N Z J Psychiatry ; 56(10): 1295-1305, 2022 10.
Article em En | MEDLINE | ID: mdl-35179048
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Clozapina / Doenças Neurodegenerativas / Demência Frontotemporal / Doença de Alzheimer Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Aust N Z J Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Clozapina / Doenças Neurodegenerativas / Demência Frontotemporal / Doença de Alzheimer Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Aust N Z J Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido